Co-infection and Cancer (R01 Clinical Trial Not Allowed)

This grant is specifically for research work related to co-infection and cancer. The project is titled "Co-infection and Cancer (R01 Clinical Trial Not Allowed)" because it's not pertaining to clinical trials. Instead, the key objective of this grant is to improve our understanding of the causal relationship between infections and cancers. Specifically, it's interested in the role played by concurrent or sequential infections by two or more pathogens (also known as co-infections, excluding those with Human Immunodeficiency Virus [HIV]) in causing cancer.

An integral part of the focus is to explore new prevention and treatment opportunities that emerge due to these co-infections. The emphasis is on populations that have not been adequately researched in this context. The term "co-infection" includes instances where a person is infected by multiple infectious agents, be they viruses, bacteria, parasites, or other microorganisms, happening together at the same time or one after the other. This can involve either short-term (acute) or long-term (chronic) infections.